Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Non-Current Debt (2017 - 2026)

Updated

Provectus Biopharmaceuticals' Non-Current Debt was $23,621 in Q4 2025, unchanged from the prior quarter.

Analysis

Provectus Biopharmaceuticals (PVCT) Non-Current Debt (2017 - 2026) Analysis & Trends

From Q4 2017 onward, Provectus Biopharmaceuticals has reported Non-Current Debt for 11 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 62.48 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 60.50 Bn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - 92,443.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,443.00
Dec 31, 2025 241,393.00
Sep 30, 2025 153,102.00
Jun 30, 2025 54,337.00
Mar 31, 2025 124,578.00
Dec 31, 2024 206,463.00
Sep 30, 2024 110,544.00
Jun 30, 2024 109,862.00
Mar 31, 2024 190,910.00
Dec 31, 2023 277,815.00
Sep 30, 2023 78,066.00
Jun 30, 2023 148,273.00
Mar 31, 2023 155,097.00
Dec 31, 2022 239,394.00
Sep 30, 2022 72,135.00
Jun 30, 2022 142,693.00
Mar 31, 2022 154,925.00
Dec 31, 2021 238,452.00
Sep 30, 2021 68,392.00
Jun 30, 2021 127,393.00
API Access

Provectus Biopharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PVCT&period=max&api_key=YOUR_API_KEY